Rapport Therapeutics (RAPP) Cash from Operations (2023 - 2026)
Rapport Therapeutics' (RAPP) quarterly Cash from Operations came in at 13061000.0 in Q1 2026, up 35.46% year-on-year from 9641974.87 in Q1 2025, and up 47.12% on a QoQ basis from 24701000.0 in Q4 2025.
Rapport Therapeutics (RAPP) Cash from Operations (2023 - 2026) Analysis & Trends
Rapport Therapeutics (RAPP) has 4 years of Cash from Operations data on file, last reported at 13061000.0 in Q1 2026.
- On a quarterly basis, Cash from Operations rose 35.46% year-over-year to 13061000.0 in Q1 2026; TTM through Mar 2026 was 80297000.0, a 19.05% decrease from a year earlier, with the FY2025 full-year figure at 87473000.0, down 34.93% from the prior year.
- Cash from Operations for Q1 2026 stood at 13061000.0, up from 24701000.0 in the prior quarter.
- Over the last five years, Cash from Operations for RAPP reached as high as 5424000.0 in Q3 2023 and fell as low as 25070000.0 in Q2 2025.
- Historically, Cash from Operations has averaged 16467545.45 across 4 years, with a median of 16415000.0 in 2024.
- Across the five-year window, Cash from Operations tumbled 202.64% in 2024 and surged 35.46% in 2026, its largest moves.
- Year by year, Cash from Operations stood at 10357000.0 in 2023, then tumbled by 39.48% to 14446000.0 in 2024, then sank by 70.99% to 24701000.0 in 2025, then jumped by 47.12% to 13061000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 13061000.0 in Q1 2026, 24701000.0 in Q4 2025, and 17465000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Rapport Therapeutics | 1.95 Bn | 1.95 Bn | - | -13.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.06 Mn |
| Mar 31, 2026 | -13.06 Mn |
| Dec 31, 2025 | -24.70 Mn |
| Dec 31, 2025 | -24.70 Mn |
| Sep 30, 2025 | -17.47 Mn |
| Sep 30, 2025 | -17.47 Mn |
| Jun 30, 2025 | -25.07 Mn |
| Jun 30, 2025 | -25.07 Mn |
| Mar 31, 2025 | -20.24 Mn |
| Mar 31, 2025 | -20.24 Mn |
| Dec 31, 2024 | -14.45 Mn |
| Dec 31, 2024 | -14.45 Mn |
| Sep 30, 2024 | -16.42 Mn |
| Sep 30, 2024 | -16.42 Mn |
| Jun 30, 2024 | -16.35 Mn |
| Jun 30, 2024 | -16.35 Mn |
| Mar 31, 2024 | -17.62 Mn |
| Mar 31, 2024 | -17.62 Mn |
| Dec 31, 2023 | -10.36 Mn |
| Dec 31, 2023 | -10.36 Mn |